Affiliated Hospital of Chengdu University
Chengdu, Sichuan, China
Hospital
Sichuan, Chengdu, Jinniu District, 二环路北二段82号 邮政编码 - 610084
About Affiliated Hospital of Chengdu University
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
1
Peking University Third Hospital
1
Clinical Trials at Affiliated Hospital of Chengdu University
During the past decade, Affiliated Hospital of Chengdu University conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Post-marketing Safety Surveillance of the Injection of DanShenDuoFenSuanYan A Real World Study
2012-06-01
2015-09-01
Completed
30,180
A Phase III Clinical Trial of AK105 Injection Combined With Anlotinib Hydrochloride Capsules Versus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC)
2020-05-01
2024-12-31
Not yet recruiting
648
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Affiliated Hospital of Chengdu University"
#1 collaborator was "Peking University" with 1 trials as a collaborator and "Shanghai Greenvalley Pharmaceutical Co., Ltd." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Affiliated Hospital of Chengdu University
According to Clinical.Site data, the most researched conditions in "Affiliated Hospital of Chengdu University" are
"Advanced Hepatocellular Carcinoma (HCC)" (1 trials) and "Adverse Drug Reaction" (1 trials). Many other conditions were trialed in "Affiliated Hospital of Chengdu University" in a lesser frequency.
Clinical Trials Intervention Types at Affiliated Hospital of Chengdu University
Most popular intervention types in "Affiliated Hospital of Chengdu University" are "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "AK105 Injection" (1 trials), "Anlotinib Hydrochloride Capsules" (1 trials) and "Sorafenib Tosylate Tablets" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Affiliated Hospital of Chengdu University
The vast majority of trials in "Affiliated Hospital of Chengdu University" are
2 trials for "All" genders.
Clinical Trials Status at Affiliated Hospital of Chengdu University
Currently, there are NaN active trials in "Affiliated Hospital of Chengdu University".
1 are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Affiliated Hospital of Chengdu University,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Affiliated Hospital of Chengdu University, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".